TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/20/2026
Back to search
Official data from USPTO
THORACOFLO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/22/2026
Trademark type
Word
Nice classes
10
Filing date
07/03/2019
Registration date
09/29/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/29/2020
Last transaction
03/22/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
FITZSIMONS, MICHAEL R
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Vascutek Limited
Representatives
Megan E. Fink Bodman PLC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Surgicalmedicaldental and veterinary apparatus and instruments; artificial vascular graftsartificial stent graftsartificial thoracicthoracoabdominal and abdominal stent graftssurgical hybrid stent graft for treatment of thoracoabdominal aortic aneurysmsstentspatches for repair and reconstruction of internal tissuevascular prostheses; surgical implants comprising artificial materials; suture materials; grafts made primarily of artificial materials being patches for repair and reconstruction of internal tissue; implantable medical systems comprised of artificial endovascular stent grafts; implantable medical devices namelyartificial endovascular stent grafts; artificial vascular grafts; artificial branched vascular grafts; artificial endovascular grafts; surgical graft materials namelyartificial endovascular graftsartificial endovascular grafts; medical systemssystems for use in artificial organ support; medical devices for measuring blood sugar for medical purposes; surgical systems namely stent delivery systems; surgical devices; devices comprising an artificial vascular graft and a stent; devices comprising an artificial vascular grafta stent and a delivery system; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in thoracoabdominal procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in aortic arch procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in endovascular procedures; thoracic stents; artificial thoracic stent grafts; thoracoabdominal stents; artificial thoracoabdominal stent grafts; artificial stent grafts; artificial stent graft systems; artificial stent graft devices; artificial stent graft systems and surgical devices comprising more than one component; artificial stent graft systems and surgical devices comprising components of more than one stent graft; artificial stent graft systems and surgical devices comprising components of more than one type of stent graft; devices comprising an artificial graft and stent joined together and compacted into a delivery system; artificial thoracic stent graft systems; artificial thoracic stent graft devices; artificial thoracoabdominal stent graft systems; artificial thoracoabdominal stent graft devices; delivery systems for artificial stents and grafts; delivery systems for artificial stent graft systems and artificial stent graft devices; medical systemsminimally invasive devices for aneurysm repair; medical devicesminimally invasive devices for aneurysm repair; medical systemsminimally invasive devices for thoracoabdominal aortic aneurysm ('TAAA') repair; medical devicesminimally invasive devices for thoracoabdominal aortic aneurysm ('TAAA') repair; cardiac valves for surgical prostheses; cardiac valve replacement systems namelyartificial cardiac valves; artificial heart valves; artificial heart valve conduits; artificial cardiac patches; artificial vascular patches; parts and fittings for all of the aforementioned goods
Publications
History of USPTO decisions and trademark events.
27 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/20/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/20/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/20/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/20/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/29/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/13/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/22/2021
FIMP
FINAL DISPOSITION PROCESSED
01/22/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/29/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/29/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/14/2020
PUBO
PUBLISHED FOR OPPOSITION
07/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/24/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/14/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/14/2020
RFNT
REFUSAL PROCESSED BY IB
12/14/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/22/2019
RFRR
REFUSAL PROCESSED BY MPU
11/22/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/01/2019
CNRT
NON-FINAL ACTION WRITTEN
10/31/2019
MAFR
APPLICATION FILING RECEIPT MAILED
10/22/2019
DOCK
ASSIGNED TO EXAMINER
10/18/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/17/2019
Continuous trademark protection
Get notified about every new filing that threatens THORACOFLO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.